GSK
4 years ago ⋅ English ⋅ 20 min read
Newsroom
ViiV Healthcare to present new data from diverse portfolio and pipeline of 2-drug and long-acting regimens for HIV treatment and prevention at IAS 2021

For media and investors onlyData to be presented underscore the commitment to developing innovative treatment and prevention options that address the changing needs of people living wit... Read More
GSK
4 years ago ⋅ English ⋅ 4 min read
Newsroom
GSK announces positive headline results from five Phase 3 studies of daprodustat for patients with anaemia due to chronic kidney disease

For media and investors onlyIssued: London UK – LSE announcementFull results to be presented at a medical meeting later this yearGlaxoSmithKline plc (LSE/NYSE: GSK) today announce... Read More
GSK
4 years ago ⋅ English ⋅ 4 min read
Newsroom
GSK unveils plan for one of Europe’s largest life science campuses in Stevenage

For media and investors only- Plan aims to unlock up to £400 million of new private investment and create up to 5,000 new highly-skilled jobs over next decade- Stevenage could bec... Read More
GSK
4 years ago ⋅ English ⋅ 4 min read
Newsroom
New study shows more needs to be done to raise public awareness on the impact of good oral health habits on overall health

For media and investors onlyAcademic studies increasingly demonstrate the links between poor oral health and systemic disease, including diabetes and cardiovascular disease, and links w... Read More
GSK
4 years ago ⋅ English ⋅ 6 min read
Newsroom
GSK and Alector announce global collaboration in immuno-neurology for two clinical stage first-in-class monoclonal antibodies for neurodegenerative diseases

For media and investors only- GSK and Alector to co-develop progranulin-elevating monoclonal antibodies, AL001 and AL101, for a range of neurodegenerative diseases, including frontotemp... Read More
GSK
4 years ago ⋅ English ⋅ 11 min read
Newsroom
Elliott Advisors (UK) letter to GSK

For media and investors onlyThe Board of GSK notes the letter issued by Elliott Advisors (UK) Limited (“Elliott”) on 1 July. The Board welcomes constructive input from all s... Read More